drug

Personalised medication advice based on pharmacogenetic testing

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
OTHER
Pre-approval / investigational in the US
Developed by Parnassia Groep
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
OTHER

Indications

Trials

1
Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
NCT05656469—Recruiting

KOLs & investigators

3
Roos van Westrhenen, Professor (PhD&MD)
Mario Juruena, Professor (MD&PhD)
Allan Young, Professor (MD&PhD)

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Parnassia Groep
company
trial
Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
NA
trial
indication
Mood Disorders
indication
Anxiety Disorders
indication
Mood Disorders
indication
Psychotic Disorders
indication
KOL
Roos van Westrhenen, Professor (PhD&MD)
KOL score —
person
Mario Juruena, Professor (MD&PhD)
KOL score —
person
Allan Young, Professor (MD&PhD)
KOL score —
person